MAQAF (Atlas Arteria) Other Current Receivables: $5.2 Mil (As of Dec. 2025)


MAQAF Atlas Arteria Ltd MAQAF
75 GF Score
Price $3.60
GF Value $4.03
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Atlas Arteria Other Current Receivables?

Atlas Arteria MAQAF +0.70% 75 Other Current Receivables is $5.2 Mil as of Dec. 2025. GuruFocus rates MAQAF with a GF Score™ of 75/100 and a GF Value™ of $4.03 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Atlas Arteria's Other Current Receivables for the quarter that ended in Dec. 2025 was $5.2 Mil.

Atlas Arteria's quarterly Other Current Receivables declined from Dec. 2024 ($5.70 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($5.18 Mil).

Atlas Arteria's annual Other Current Receivables declined from Dec. 2023 ($21.02 Mil) to Dec. 2024 ($5.70 Mil) and declined from Dec. 2024 ($5.70 Mil) to Dec. 2025 ($5.18 Mil).

Atlas Arteria Other Current Receivables Related Terms

Atlas Arteria Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Atlas Arteria's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atlas Arteria Other Current Receivables Chart

Atlas Arteria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.31 1.67 21.02 5.70 5.18

Atlas Arteria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.02 0.00 5.70 0.00 5.18
MAQAF
75GF Score
Atlas Arteria Ltd MAQAF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atlas Arteria Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $5.2 Mil mean?
Atlas Arteria (MAQAF) has a Other Current Receivables of $5.2 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Atlas Arteria and its competitors.
Is Atlas Arteria's Other Current Receivables too high?
Atlas Arteria's current Other Current Receivables is $5.2 Mil. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's Other Current Receivables compare to competitors?
Atlas Arteria's Other Current Receivables of $5.2 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Construction company?
A good Other Current Receivables depends on the Construction industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Atlas Arteria and its competitors. Atlas Arteria's current Other Current Receivables is $5.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (MAQAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.03, compared to a current price of $3.60 — trading 10.7% below its estimated fair value. The current Other Current Receivables is $5.2 Mil. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Atlas Arteria (MAQAF), the current Other Current Receivables is $5.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (MAQAF) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of $3.60 is trading 10.7% below its estimated GF Value™ of $4.03. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for MAQAF:

  • Other Current Receivables: $5.2 Mil
  • GF Value™: $4.03 vs. price of $3.60 (10.7% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the MAQAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atlas Arteria Business Description

Other Exchanges M82:GermanyALX:Australia
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score

Get the complete analysis for MAQAF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.60
Price
$4.03
GF Value